In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism

Journal of Neural Transmission

Volumn 118, Issue 8, 2011, Pages 1191-1197

  Srulijes, Karin ^a   Mallien, Grit ^b   Bauer, Sarah ^a   Dietzel, Elisabeth ^a   Gröger, Adriane ^a   Ebersbach, Georg ^b   Berg, Daniela ^a   Maetzler, Walter ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Movement Disorder Clinic   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Dysarthria; Executive functions; Neuropsychology; PSP parkinsonism; Richardson's syndrome

Indexed keywords

MEMBRANE PROTEIN; PHOSPHO TAU PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; IN VIVO STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL HISTORY; MENTAL DISEASE; NEUROLOGIC DISEASE; OUTPATIENT DEPARTMENT; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROGRESSIVE SUPRANUCLEAR PALSY PARKINSONISM; RICHARDSON SYNDROME; SPEECH;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; RETROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNDROME;

EID: 80051588507     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0563-8     Document Type: Article

References (33)

1. D Aarsland I Litvan JP Larsen 2001 Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease J Neuropsychiatry Clin Neurosci 13 1 42 49 11207328 10.1176/appi.neuropsych.13.1.42 1:STN:280:DC%2BD3M3gsVWqsw%3D%3D (Pubitemid 32151915)
2. F Agosta VS Kostic S Galantucci S Mesaros M Svetel E Pagani E Stefanova M Filippi 2010 The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: A VBM-DARTEL study Eur J Neurosci 32 4 640 647 20597976 10.1111/j.1460-9568.2010.07304.x
3. S Birdi AH Rajput M Fenton JR Donat B Rozdilsky C Robinson R Macaulay D George 2002 Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases Mov Disord 17 6 1255 1264 12465065 10.1002/mds.10211 (Pubitemid 36041339)
4. BF Boeve AE Lang I Litvan 2003 Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia Ann Neurol 54 Suppl 5 S15 S19 12833363 10.1002/ana.10570 (Pubitemid 36760148)
5. A Brusa GL Mancardi O Bugiani 1980 Progressive supranuclear palsy 1979: an overview Ital J Neurol Sci 1 4 205 222 7338456 1:STN:280:DyaL387ms1KqtQ%3D%3D (Pubitemid 11220141)
6. J Cambier M Masson F Viader J Limodin A Strube 1985 Frontal syndrome of progressive supranuclear palsy Revue neurologique 141 8-9 528 536 4089415 1:STN:280:DyaL287it1emtw%3D%3D (Pubitemid 15240929)
7. JL Cummings M Mega K Gray S Rosenberg-Thompson DA Carusi J Gornbein 1994 The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 12 2308 2314 7991117 1:STN:280:DyaK2M%2FotlWisw%3D%3D (Pubitemid 24382728)
8. B Dubois A Slachevsky I Litvan B Pillon 2000 The FAB: a Frontal Assessment Battery at bedside Neurology 55 11 1621 1626 11113214 1:STN:280:DC%2BD3M%2FnvFSrsA%3D%3D
9. Fahn S, Elton RL (1987) Committee MotUD Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson's disease, vol 2. MacMillan Health Care Information, New York, pp 153-164
10. MF Folstein SE Folstein PR McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 3 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
11. WR Gibb AJ Lees 1988 The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 6 745 752 2841426 10.1136/jnnp.51.6.745 1:STN:280:DyaL1czgtVSqsg%3D%3D
12. S Gilman PA Low N Quinn A Albanese Y Ben-Shlomo CJ Fowler H Kaufmann T Klockgether AE Lang PL Lantos I Litvan CJ Mathias E Oliver D Robertson I Schatz GK Wenning 1999 Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 1 94 98 10223419 10.1016/S0022-510X(98)00304-9 1:STN:280:DyaK1M3jsl2gsg%3D%3D (Pubitemid 29155424)
13. LI Golbe PA Ohman-Strickland 2007 A clinical rating scale for progressive supranuclear palsy Brain 130 Pt 6 1552 1565 17405767 10.1093/brain/awm032 (Pubitemid 47355915)
14. J Grafman I Litvan M Stark 1995 Neuropsychological features of progressive supranuclear palsy Brain Cogn 28 3 311 320 8546857 10.1006/brcg.1995.1260 1:STN:280:DyaK28%2FntV2kuw%3D%3D
15. KA Jellinger 2008 Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy Neuro-degener Dis 5 6 339 346 10.1159/000121388 1:CAS:528:DC%2BD1cXhtV2jurfM
16. LD Kaat AJ Boon W Kamphorst R Ravid HJ Duivenvoorden JC van Swieten 2007 Frontal presentation in progressive supranuclear palsy Neurology 69 8 723 729 10.1212/01.wnl.0000267643.24870.26 (Pubitemid 47300928)
17. KJ Kluin NL Foster S Berent S Gilman 1993 Perceptual analysis of speech disorders in progressive supranuclear palsy Neurology 43 3 Pt 1 563 566 8451002 1:STN:280:DyaK3s7ps1yqsw%3D%3D (Pubitemid 23088493)
18. K Kluin S Gilman N Foster A Sima C D'Amato L Bruch L Bluemlein R Little J Johanns 2001 Neuropathological correlates of dysarthria in progressive supranuclear palsy Arch Neurol 58 2 265 269 11176965 10.1001/archneur.58.2.265 1:STN:280:DC%2BD3M7ntFWksQ%3D%3D (Pubitemid 32163164)
19. I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin CG Goetz LI Golbe J Grafman JH Growdon M Hallett J Jankovic NP Quinn E Tolosa DS Zee 1996 Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1 1 9 8710059 1:STN:280:DyaK283ptFSjtA%3D%3D (Pubitemid 26243849)
20. I Litvan KP Bhatia DJ Burn CG Goetz AE Lang I McKeith N Quinn KD Sethi C Shults GK Wenning 2003 Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders Mov Disord 18 5 467 486 12722160 10.1002/mds.10459 (Pubitemid 36656531)
21. W Maetzler S Keller J Michelis N Koehler E Stransky C Becker C Schulte A Melms T Gasser D Berg 2009 No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases Neurobiol Dis 35 2 296 301 19481150 10.1016/j.nbd.2009.05.014 1:CAS:528:DC%2BD1MXotFCgtLw%3D
22. RS Marin RC Biedrzycki S Firinciogullari 1991 Reliability and validity of the Apathy Evaluation Scale Psychiatry Res 38 2 143 162 1754629 10.1016/0165-1781(91)90040-V 1:STN:280:DyaK38%2FpsVSnug%3D%3D
23. U Nath Y Ben-Shlomo RG Thomson AJ Lees DJ Burn 2003 Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study Neurology 60 6 910 916 12654952 1:STN:280:DC%2BD3s7ktVWntQ%3D%3D (Pubitemid 36348920)
24. SS O'Sullivan LA Massey DR Williams L Silveira-Moriyama PA Kempster JL Holton T Revesz AJ Lees 2008 Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain 131 Pt 5 1362 1372 18385183
25. Oswald W, Fleischmann U (1997) Das Nürnberger Altersinventar. Hogrefe, Göttingen
26. JC Richardson J Steele J Olszewski 1963 Supranuclear Ophthalmoplegia, Pseudobulbar Palsy, Nuchal Dystonia and Dementia. A clinical report on eight cases of "heterogenous system degeneration" Trans Am Neurol Assoc 88 25 29 14272249 1:STN:280:DyaF2M%2Fns1yjtA%3D%3D
27. S Sachin G Shukla V Goyal S Singh V Aggarwal M Behari 2008 Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy Neurology India 56 2 122 126 18688134 10.4103/0028-3886.41987 1:STN:280:DC%2BD1crgsF2htA%3D%3D
28. A Schrag Y Ben-Shlomo NP Quinn 1999 Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study Lancet 354 9192 1771 1775 10577638 10.1016/S0140-6736(99)04137-9 1:STN:280: DC%2BD3c%2FktlGksg%3D%3D
29. Skodda S, Visser W, Schlegel U (2010) Acoustical analysis of speech in progressive supranuclear palsy. J Voice (epub ahead of print)
30. DR Williams AJ Lees 2009 Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges Lancet Neurol 8 3 270 279 19233037 10.1016/S1474-4422(09)70042-0
31. DR Williams R de Silva DC Paviour A Pittman HC Watt L Kilford JL Holton T Revesz AJ Lees 2005 Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism Brain 128 Pt 6 1247 1258 15788542 10.1093/brain/awh488 (Pubitemid 40826179)
32. DR Williams JL Holton C Strand A Pittman R de Silva AJ Lees T Revesz 2007 Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome Brain 130 Pt 6 1566 1576 17525140 10.1093/brain/awm104 (Pubitemid 47355935)
33. DR Williams JL Holton K Strand T Revesz AJ Lees 2007 Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy Mov Disord 22 15 2235 2241 17712855 10.1002/mds.21698